All Type of News
DaewoongBio eyes markets of finished pharmaceuticals
DaewoongBio, a local maker for pharmaceutical raw materials, seeks to take the lead in the domestic and overseas market by launching a new drug business unit, a company official said on April 19.
The business unit ...
Chong Kun Dang fosters ‘green management’ culture
Chong Kun Dang Pharmaceutical Co., the nation’s leading drug manufacturer, is taking the lead in local firms’ green drive by launching a green pharma campaign.
In a recent forum, the company said it saved a total o...
Snowballing debts haunt clinics
35 percent of general clinics hold an average 380 million won in debt and OB & GY clinics see their liabilities soar to 800 million won on average.
The Korea Medical Association revealed the information based on th...
Choong-wae announces development of anticancer agent to kill leukemia stem cells
Choong-wae Pharm announced on April 19 the development of an anti-cancer medicine that interrupts biochemical signals to eradicate leukemia stem cells without affecting normal cells.
Speaking at a seminar at the Am...
Samjin looks to newly emerging appetite stimulant market
Samjin Pharm said the annual revenue of its OTC appetite stimulant drug “Trestan” will reach 10 billion won, thanks much to increasing market demand.
“The domestic market for appetite-stimulating pharmaceuticals, w...
HIRAS to revise economic effectiveness guideline for medicines
The Health Insurance Review Assessment and Service said on April 19 that it is considering modifying the economic effectiveness guideline for medicines by reflecting the recent scientific outcomes and local research s...
Who will head Korea Pharmaceutical Manufacturers Association?
The Korea Pharmaceutical Manufacturers Association, a leading business lobby, says it will appoint a new president and executives from the outside until the middle of next month.
The organization said it has contac...
Government to withhold corporate tax cut
The government is considering withholding or scrapping tax cut programs for facility investment, which will affect some drug makers who have an intention of reconstructing their cGMP plants.
So far, companies have ...
Green Cross seeking to go global with flu vaccine
Green Cross Corporation said on April 20 that the company is set to export $6 million won worth of Influenza A (H1N1) flu vaccines to the World Health Organization (WHO).
Last September, Green Cross has submitted a...
Government to scrap preferential treatment fee system at night-time
Doctors working at night will not benefit from preferential treatment fees.
The government plans to lift the current differential doctor fee in a bid to ensure the financial stability of the national health insuran...
